Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (17)

2023

  1. Diverticulitis with abscess formation: Outcomes of non-operative management and nomogram for predicting emergency surgery: The Diplicab Study Collaborative Group

    Surgery (United States), Vol. 174, Núm. 3, pp. 492-501

2020

  1. Imported Mansonella perstans infection in Spain

    Infectious Diseases of Poverty, Vol. 9, Núm. 1

2019

  1. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality

    PLoS ONE, Vol. 14, Núm. 9

  2. Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains

    Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251

2018

  1. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients

    Critical Care, Vol. 22, Núm. 1

2017

  1. Factores de riesgo para la colonización por enterobacterias productoras de carbapenemasas en el momento de admisión en una UCI quirúrgica: estudio retrospectivo

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 6, pp. 333-337

2016

  1. Basis for selecting optimum antibiotic regimens for secondary peritonitis

    Expert Review of Anti-Infective Therapy, Vol. 14, Núm. 1, pp. 109-124

  2. Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 1, pp. 32-39

2015

  1. Biomarkers (procalcitonin, C reactive protein, and lactate) as predictors of mortality in surgical patients with complicated intra-abdominal infection

    Surgical Infections, Vol. 16, Núm. 3, pp. 346-351

  2. Estudio observacional basado en la práctica clínica sobre la utilización de micafungina en Unidades de Cuidados Críticos Quirúrgicos

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 132-138

  3. Estudio observacional basado en la práctica diaria identificando factores asociados con la administración de dosis altas de tigeciclina en el tratamiento de la peritonitis secundaria en pacientes críticos

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 1, pp. 47-53

  4. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study

    Journal of Critical Care, Vol. 30, Núm. 3, pp. 537-542

2014

  1. Bugs, hosts and ICU environment: Countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting

    Revista Espanola de Anestesiologia y Reanimacion

  2. Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections

    Expert Review of Anti-Infective Therapy, Vol. 12, Núm. 11, pp. 1311-1324

  3. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 6, pp. 1624-1632

2013

  1. Gérmenes, huéspedes y el entorno de la UCI: Contrarrestando la panresistencia en la microbiota nosocomial para tratar las infecciones bacterianas en cuidados críticos

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 4, pp. 312-331

2005

  1. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs Differ

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 3, pp. 996-1001